Inventor · disambiguated record
Victor J. Dzau
Also filed as: DZAU VICTOR · DZAU VICTOR J
30 granted patents·20 pending applications·1,582 citations·filing 1993–2023
98Inventor score
Files withUNIV LELAND STANFORD JUNIOR12UNIV DUKE10BRIGHAM & WOMENS HOSPITAL7DZAU VICTOR J5DZAU VICTOR4
Top patents by PatentIndex Score
50 records- 0198US5891459AEnhancement of vascular function by modulation of endogenous nitric oxide production or activityUNIV LELAND STANFORD JUNIOR·Filed 1995·Granted Apr 6, 1999·262 cites·22 claims
- 0297US6646006B2Enhancement of vascular function by modulation of endogenous nitric oxide production or activityUNIV LELAND STANFORD JUNIOR·Filed 2002·Granted Nov 11, 2003·66 cites·45 claims
- 0395US6642208B2Enhancement of vascular function by modulation of endogenous nitric oxide production or activityUNIV LELAND STANFORD JUNIOR·Filed 2001·Granted Nov 4, 2003·33 cites·21 claims
- 0494US5922687AIntracellular delivery of nucleic acids using pressureUNIV LELAND STANFORD JUNIOR·Filed 1996·Granted Jul 13, 1999·233 cites·90 claims
- 0594US5631237AMethod for producing in vivo delivery of therapeutic agents via liposomesFiled 1994·Granted May 20, 1997·166 cites·10 claims
- 0694US5428070ATreatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activityUNIV LELAND STANFORD JUNIOR·Filed 1993·Granted Jun 27, 1995·226 cites·5 claims
- 0791US7638128B2Method of enhancing cardiac tissue repair by administering a SFRP polypeptideBRIGHAM & WOMENS HOSPITAL·Filed 2006·Granted Dec 29, 2009·14 cites·4 claims
- 0890US6821956B2Therapeutic use of cis-element decoys in vivoBRIGHAM & WOMENS HOSPITAL·Filed 2001·Granted Nov 23, 2004·27 cites·4 claims
- 0990US5945452ATreatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activityUNIV LELAND STANFORD JUNIOR·Filed 1997·Granted Aug 31, 1999·105 cites·10 claims
- 1090US5785965AVEGF gene transfer into endothelial cells for vascular prosthesisUNIV LELAND STANFORD JUNIOR·Filed 1996·Granted Jul 28, 1998·139 cites·11 claims
- 1188US8703710B2Method of reducing cell death by administering a paracrine factor of a mesenchymal stem cellDZAU VICTOR J·Filed 2010·Granted Apr 22, 2014·6 cites·20 claims
- 1285US5821234AInhibition of proliferation of vascular smooth muscle cellUNIV LELAND STANFORD JUNIOR·Filed 1993·Granted Oct 13, 1998·78 cites·10 claims
- 1379US9279012B2Method of reducing cell death by administering a nucleic acid encoding a paracrine factor of a mesenchymal stem cellBRIGHAM & WOMENS HOSPITAL·Filed 2014·Granted Mar 8, 2016·1 cites·21 claims
- 1478US6337321B1Enhancement of vascular function by modulation of endogenous nitric oxide production or activityUNIV LELAND STANFORD JUNIOR·Filed 1998·Granted Jan 8, 2002·25 cites·8 claims
- 1577US6352555B1Methods for implanting cellsBRIGHAM AND WOMENS HOSPITAL IN·Filed 1999·Granted Mar 5, 2002·46 cites·12 claims
- 1677US6199554B1Method and apparatus for combining injury-mediated therapy and drug deliveryBRIGHAM & WOMENS HOSPITAL·Filed 1998·Granted Mar 13, 2001·54 cites·28 claims
- 1776US10695378B2Direct reprogramming of cells to cardiac myocyte fateUNIV DUKE·Filed 2018·Granted Jun 30, 2020·1 cites·22 claims
- 1876US6774118B1Therapeutic use of CIS-element decoys in vivoBRIGHAM & WOMENS HOSPITAL·Filed 1995·Granted Aug 10, 2004·26 cites·1 claims
- 1975US10130637B2Inhibition of histone methyltransferase for cardiac reprogrammingUNIV DUKE·Filed 2013·Granted Nov 20, 2018·1 cites·21 claims
- 2075US5869462AInhibition of proliferation of vascular smooth muscle cellUNIV LELAND STANFORD JUNIOR·Filed 1995·Granted Feb 9, 1999·44 cites·8 claims
- 2172US9353168B2Method of reducing cell death by administering a paracrine factor derived from a mesenchymal stem cellBRIGHAM & WOMENS HOSPITAL·Filed 2014·Granted May 31, 2016·0 cites·19 claims
- 2270US9987309B2Direct reprogramming of cells to cardiac myocyte fateDZAU VICTOR J·Filed 2011·Granted Jun 5, 2018·1 cites·18 claims
- 2368US11534464B2Direct reprogramming of cells to cardiac myocyte fateUNIV DUKE·Filed 2020·Granted Dec 27, 2022·0 cites·10 claims
- 2468US8129344B2Method of reducing cell death by administering a Sfrp polypeptideDZAU VICTOR·Filed 2008·Granted Mar 6, 2012·0 cites·4 claims
- 2564US2004082659A1Enhancement of vascular function by modulation of endogenous nitric oxide production or activityUNIV LELAND STANFORD JUNIOR·Filed 2003·Application pending·0 cites
- 2663US2017128526A1Stem cell derived factors for treating pathologic conditionsBRIGHAM & WOMENS HOSPITAL INC·Filed 2016·Application pending·0 cites
- 2762US2024197640A1Systems and methods for exosome delivery of micrornas for cellular reprogrammingUNIV DUKE·Filed 2023·Application pending·0 cites
- 2859US6579313B2Methods for implanting cellsBRINGHAM AND WOMEN S HOSPITAL·Filed 2002·Granted Jun 17, 2003·15 cites·9 claims
- 2959US2004229833A1Therapeutic use of cis-element decays in vivoFiled 2004·Application pending·0 cites
- 3059US2023313160A1Compositions and methods for controlling blood pressureUNIV DUKE·Filed 2022·Application pending·0 cites
- 3159US2020009197A1Compositions and methods for the reprogramming of cells into cardiomyocytesUNIV DUKE·Filed 2019·Application pending·0 cites
- 3257US11512290B2Compositions and methods for cellular reprogrammingUNIV DUKE·Filed 2019·Granted Nov 29, 2022·0 cites·18 claims
- 3357US2019192533A1Inhibition of histone methyltransferase for cardiac reprogrammingUNIV DUKE·Filed 2018·Application pending·0 cites
- 3456US12285444B2Multicistronic miRNA delivery for cardiac reprogrammingUNIV DUKE·Filed 2021·Granted Apr 29, 2025·0 cites·11 claims
- 3556US2003186922A1Therapeutic use of cis-element decoys in vivoFiled 2003·Application pending·0 cites
- 3655US2007258951A1Methods of treating cardiac disordersDZAU VICTOR·Filed 2006·Application pending·0 cites
- 3752US2004266712A1Selective inhibition of vascular smooth muscle cell proliferationFiled 2004·Application pending·0 cites
- 3852US2002128217A1Therapeutic use of cis-element decoys in vivoFiled 2001·Application pending·0 cites
- 3951US2003022870A1Methods of treating cardiac disordersFiled 2002·Application pending·0 cites
- 4048US2011071086A1Compositions for tissue repair/regenerationDZAU VICTOR J·Filed 2008·Application pending·0 cites
- 4147US2008070830A1Homing of cells to myocardiumDZAU VICTOR J·Filed 2007·Application pending·0 cites
- 4244US2018042969A1Compositions and methods for the reprogramming of cells into cardiomyocytesUNIV DUKE·Filed 2015·Application pending·0 cites
- 4341US2011044947A1Methods of treating cardiac disordersDZAU VICTOR·Filed 2010·Application pending·0 cites
- 4441US2012172306A1Use of HASF as a Protective Agent Against Ischemic Tissue DamageMIROTSOU MARIA·Filed 2010·Application pending·0 cites
- 4539US5556780ACDNAS encoding mouse and rat type-2 angiotensin II receptors and their expression in host cellsTRUSTEES FOR THE LELAND STANFO·Filed 1993·Granted Sep 17, 1996·7 cites·5 claims
- 4639US2004258669A1Mesenchymal stem cells and methods of use thereofFiled 2003·Application pending·0 cites
- 4738US2006211600A1Stem cell-derived factors for treating pathologic conditionsDZAU VICTOR·Filed 2006·Application pending·0 cites
- 4832US6294384B1Compositions and methods based upon an isoform of p53BRIGHAM & WOMENS HOSPITAL·Filed 1999·Granted Sep 25, 2001·2 cites·20 claims
- 4932US2011091430A1Mesenchymal stem cells and methods of use thereofDZAU VICTOR J·Filed 2010·Application pending·0 cites
- 5027US5766901AApparatus and method for delivering a nucleotide into cell nucleiUNIV LELAND STANFORD JUNIOR·Filed 1995·Granted Jun 16, 1998·4 cites·22 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →